All Posts by Date or last 15, 30, 90 or 180 days.
also by Lloyd: MacPerformanceGuide.com and WindInMyFace.com

Thank you for buying via links and ads on this site,
which earn me advertising fees or commissions.
As an Amazon Associate I earn from qualifying purchases.

Other World Computing...
B&H Photo...
Amazon
As an Amazon Associate I earn from qualifying purchases.
Memory Upgrades for 2019 Mac Pro - Save Up to 65% vs Factory Costs
Upgrade the memory of your 2020 iMac up to 128GB

Current COVID Vaccines May Not Provide High Level, Sustained Protection Against Infection or Transmission With Omicron, Even After Multiple Boosts...

re: COVID
re: ethics in medicine
re: CDC Says COVID-19 Antibody Seroprevalance is 83%, 2.1 Infections per Case Estimated

When Will you be getting Jabbed or Boosted?

Don’t be a sucker—thinking past the sale is what they want you to do. First ask whether it makes sense for you personally. Including that fact that if you have natural immunity (surely 95% of the population now does), that is far superior.

Covid-19 Vaccines — Immunity, Variants, Boosters

2022-09-18

...

Boosting every 4 to 6 months to maintain high serum neutralizing antibody titers may not be a practical or desirable long-term strategy. Boosting with mRNA vaccines is also not risk-free. Moreover, frequent boosting recommendations may worsen “booster fatigue” in the general population, given that to date only 47% of eligible persons in the United States have received any booster dose. Expert opinion on the benefits of frequent boosters remains divided, communications from public health authorities have been viewed as confusing and overpromising, and vaccine hesitancy remains a major challenge. Frequent booster recommendations may also distract from the critical goal of vaccinating the large number of unvaccinated persons in the United States and throughout the world and may further exacerbate global health inequities.

...

Current vaccines may not provide high level, sustained protection against infection or transmission with omicron, even after multiple boosts and also after the introduction of updated omicron specific vaccines.

Instead, the most important goal of COVID-19 vaccination should be to provide long-term protection against severe disease, hospitalization and death from current and future variants … clinical benefits of the updated boosters as compared with the current vaccines are not clear … Plans for boosters should therefore be based on robust scientific data that shows substantial and sustained increases in prevention of severe disease rather than on short-term increases in neutralizing antibody titers. 

...

Conclusions

The Covid-19 pandemic appears to be transitioning from a hyperacute phase to an endemic phase. Current Covid-19 vaccines are less effective at blocking infection with the omicron variant than at blocking infection with prior variants, but protection against severe disease remains largely preserved.

The primary goal of Covid-19 vaccines should be to provide long-term protection against severe disease, hospitalization, and death. It is therefore important for studies of Covid-19 vaccines and boosters to evaluate not only short-term neutralizing antibody titers but also durability of antibody responses, memory B-cell responses, and cross-reactive T-cell responses.

WIND: there is no “robust scientific data”; there is no data at all.

Why would anyone of good physical health even consider these untested Jabs? Lunatics and crackpots are running the show lacking any supporting science.

Read that again; real results are not the same as proxy results:

Plans for boosters should therefore be based on robust scientific data that shows substantial and sustained increases in prevention of severe disease rather than on short-term increases in neutralizing antibody titers

AMEN

View all handpicked deals...

Apple 13.3" MacBook Pro (M2, Space Gray)
$1699 $1499
SAVE $200

diglloyd.com | Terms of Use | PRIVACY POLICY
Contact | About Lloyd Chambers | Consulting | Photo Tours
Mailing Lists | RSS Feeds | Twitter
Copyright © 2020 diglloyd Inc, all rights reserved.
Display info: __RETINA_INFO_STATUS__